PDF《Kyrgyzstan》

2017 Measles cases by age group and vaccination status,

2017 Source: ?Measles and rubella elimination Annual Status Update report,

2017 Note: Excludes imported cases Supplementary immunization activities Year Target age Vaccine used % Coverage

2015 9M-9Y MR 96%

2015 1-20Y MR 92% Source: Supplementary immunization activities, WHO, Data and Statistics, Immunization Monitoring and Surveillance (http://www.who.int/immunization/monitoring_surveillance/data/en/) MR = measles-rubella vaccine ND = Data not available 1dot=1case ?B3 ?D8 ?H1 ?D9

0 20

40 60

80 100 <

1 1-4 5-9 10-14 15-19 20-29

30 + % of cases Age group (years)

0 doses

1 dose

2 or more doses Suspected measles cases Confirmed measles cases Discarded as non- measles Measles incidence Genotypes detected Laboratory Epi- linked Clinically Total

2013 ND ND ND ND

1 ND 0.2 ND

2014 575

318 0

0 318

119 54.3 D8

2015 21

019 1300

2263 14

216 17

779 2634 2985.6 D8

2016 84

0 0

0 0

82 0 ND

2017 161

5 0

0 5

156 0.5 B3 Measles incidence, epidemiologic and virologic characteristics, 2013-2017 Measles surveillance and laboratory performance indicators, 2013-2017 Source: Measles and rubella elimination Annual Status Update report, 2013-2017 Incidence calculated per

1 million population ND = Data not available;

NA= Not applicable Source: ASU 2013-2017 ND = Data not available;

NA= Not applicable A proficient laboratory is WHO accredited and/or has an established quality assurance programme with oversight by a WHO accredited laboratory Rubella incidence, epidemiologic and virologic characteristics, 2013-2017 Rubella surveillance and laboratory performance indicators, 2013-2017 Source: Measles and rubella elimination Annual Status Update report, 2013-2017 Incidence calculated per

1 million population ND = Data not available;

NA= Not applicable Source: ASU 2013-2017 ND = Data not available;

NA= Not applicable A proficient laboratory is WHO accredited and/or has an established quality assurance programme with oversight by a WHO accredited laboratory Surveillance performance indicators and targets a.?Rate of discarded cases: at least

2 discarded measles or rubella cases per

100 000 population b.?% cases with adequate laboratory investigation: ≥ 80% c.?% origin of infection known: ≥ 80% d.?Rate of viral detection: ≥ 80%? Measles and rubella elimination country profile Kyrgyzstan Discarded non- measlesrate %1stsub- nationalunit with≥2 discarded cases % cases with adequate laboratory investigation % origin of infection known # specimen testedfor measles %positive for measles Rateofviral detection %WHOand proficient labs

2013 ND ND ND ND ND ND ND ND

2014 4.6 100% 10.2% 100%

2190 ND

100 ND

2015 1.2 45.3% 100% 0%

111 0%

0 100%

2016 1.2 54.7% 100% 0%

175 0%

0 100%

2017 2.5 100% 100% 100%

161 3.1% 50% 100% Suspected rubella cases Confirmed rubella cases Discarded as non- rubella Rubella incidence Genotypes detected Laboratory Epi- linked Clinically Total

2013 ND ND ND ND

12 ND 2.1 ND

2014 93

12 0

0 12

81 4.4 ND

2015 286

2 0

98 100

186 16.7 ND

2016 17

3 0

0 3

17 0.5 ND

2017 161

4 0

0 4

157 0.5 ND Discarded non- rubella rate % 1st sub- national unit with ≥

2 discarded cases % cases with adequate laboratory investigtion % origin of infection known # specimen tested for rubella % positive for rubella Rate of viral detection % WHO and proficient labs

2013 ND ND ND ND ND ND ND ND

2014 0.9 88.8% 87.8% ND